| Literature DB >> 25567903 |
Bernard Crespi1, Kyle Summers2, Steve Dorus3.
Abstract
Previous studies have postulated that X-linked and autosomal genes underlying human intellectual disability may have also mediated the evolution of human cognition. We have conducted the first comprehensive assessment of the extent and patterns of positive Darwinian selection on intellectual disability genes in humans. We report three main findings. First, as noted in some previous reports, intellectual disability genes with primary functions in the central nervous system exhibit a significant concentration to the X chromosome. Second, there was no evidence for a higher incidence of recent positive selection on X-linked than autosomal intellectual disability genes, nor was there a higher incidence of selection on such genes overall, compared to sets of control genes. However, the X-linked intellectual disability genes inferred to be subject to recent positive selection were concentrated in the Rho GTP-ase pathway, a key signaling pathway in neural development and function. Third, among all intellectual disability genes, there was evidence for a higher incidence of recent positive selection on genes involved in DNA repair, but not for genes involved in other functions. These results provide evidence that alterations to genes in the Rho GTP-ase and DNA-repair pathways may play especially-important roles in the evolution of human cognition and vulnerability to genetically-based intellectual disability.Entities:
Keywords: genetic; genomic; intellectual disability; positive selection
Year: 2009 PMID: 25567903 PMCID: PMC3352458 DOI: 10.1111/j.1752-4571.2009.00098.x
Source DB: PubMed Journal: Evol Appl ISSN: 1752-4571 Impact factor: 5.183
Mental retardation genes from the compilation of Inlow and Restifo (2004), Appendix 1 that show evidence of recent positive selection in one or more HapMap populations (Voight et al. 2006)
| FACL4 (1 Yri), FGD1 (1 Ceu), FMR1 (2 Ceu), OPHN1 (3 Ceu) |
| AMT (64 Asn, 4 Yri, 0.0526), ALG12 (7 Ceu, 2 Asn, 0.0502), ASL (13 Asn, 14 Yri), CBS (2 Ceu), CLN1 (5 Asn, 2 Yri, 0.064) CREBBP (1 Yri), DBT (5 Ceu), DUOX2 (6 Ceu), ERCC8 (3 Ceu), FANCA (3 Yri), FANCC (1 Yri & 1 Asn), FOXE1 (4 Yri), GCS1 (20 Ceu), GNPAT (4 Ceu), GPH (7 Ceu, 6 Yri, 0.080), GSS (5 Ceu, 6 Asn), GUSB (13 Yri, 13 Asn), HEXA (7 Ceu), MYO5A (4 Ceu), NBS1 (2 Ceu & 2 Yri), NDUFS4 (1 Ceu, 1 Yri), NDUFV1 (24 Asn), PEX1 (7 Yri, 3 Ceu 0.094), POMT1 (2 Yri), PPOX (14 Yri), SARA2 (5 Yri), SLC12A1 (2 Ceu), SLC12A6 (5 Ceu), TTF1 (2 Ceu) |
Shown after each gene is the number of contiguous genes in the inferred selective sweep, and the population showing evidence of selection at P < 0.05. Population and P-value data are also presented for these genes from any additional population showing evidence of selection at marginally nonsignificant P-values of 0.05 < P < 0.10. Ceu = European, Yri = African, Asn = Asian.
Data on chromosomal position (X linked vs autosomal) and proportions of genes inferred as subject to recent positive selection, as evidenced by selective sweeps in humans, for mental retardation genes with different biological functions as listed in Inlow and Restifo (2004), Appendix 1
| Biological function | X-linked | Autosomal | Selected, this function | Selected, other functions | ||
|---|---|---|---|---|---|---|
| CNS | 23/34 | 104/214 | 0.043 | 18/123 | 15/130 | 0.58 |
| Lysosomal | 2/44 | 27/225 | 0.19 | 3/29 | 29/240 | 1.0 |
| DNA repair | 0/44 | 9/227 | 0.36 | 4/9 | 29/255 | 0.016 |
| Metabolic | 10/44 | 85/227 | 0.083 | 9/94 | 24/170 | 0.34 |
| Transcription regulation | 3/43 | 18/226 | 0.76 | 3/21 | 30/241 | 0.74 |
| Signaling pathway | 13/43 | 20/226 | 0.0004 | 2/30 | 31/232 | 0.39 |
| Protein modification | 0/44 | 17/224 | 0.084 | 3/17 | 30/244 | 0.46 |
Fisher's exact test was used to compare proportions. Biological functions listed as uncertain (with a “?”) in Inlow and Restifo (2004), Appendix 1 are not included in the compilations, and seven genes have data on chromosomal location and biological function, but no data on the presence or absence of positive selection.
Key characteristics of intellectual disability genes that have been inferred as subject to recent positive selection in the human lineage
| Gene | Phenotypic effects | Developmental-genetic functions |
|---|---|---|
| Genes in Rho-GTPase pathway | ||
| FGD1 | Mutations cause Aarskog-Scott syndrome (FacioGenital Dysplasia), which involves macrocephaly and genital anomalies ( | FGD1 gene product acts as upstream effector of Rho GTP-ases, and is involved in neurite outgrowth and dendritic spine development ( |
| FMR1 | Mutations cause Fragile X syndrome, which involves macrocephaly, macroorchidism (large testis), reduced cerebellar vermis, and a high incidence of autism ( | FMR1 gene product, FMRP, interacts with CYFIP1,2, which mediate Rho GTPase activation ( |
| OPHN1 | Mutations involve cerebellar hypoplasia, hypogonadism, and macrocephaly in a notable proportion of cases ( | OPHN1 gene product regulates RhoA activity, affects glutamatergic signaling; mouse mutants show immature dendritic spines ( |
| Genes in DNA repair pathways | ||
| FANCA & FANCC | Mutations cause Fanconi Anemia, an autosomal recessive condition that involves microcephaly, growth retardation, bone marrow failure, skeletal malformations and increased cancer risk ( | FANC genes maintain genomic stability and are required for neural stem cell maintenance in brain development; aging of stem cell pools may underlie Fanconi Anemia phenotypes ( |
| NBS1 | Mutations cause Nijmegen Breakage syndrome, an autosomal recessive condition characterized by microcephaly, immunodeficiency, increased cancer risk, and growth retardation ( | NBS1 gene product maintains genomic stability via repair of double-stranded DNA breaks, and helps to maintain telomeres ( |
| ERCC8 | Mutations are one cause of Cockayne syndrome, an autosomal recessive condition involving microcephaly, growth retardation, hypogonadism, and symptoms of premature aging ( | ERCC8 gene product functions in repair of damage in actively-transcribed genes ( |